Pharm Flashcards

(270 cards)

1
Q

heart: (inward/outward) current: the potassium current, I-K1

A

outward (contributes most to repolarization of cardiac myocyte after an AP, phase 4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

heart: (inward/outward) current: the fast sodium current, I-Na

A

inward (phase 0 of AP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

heart: (inward/outward) current: the L-type calcium current, I-Ca-L

A

inward, during plateau phase of AP, phase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

heart: (inward/outward) current: the pacemaker current, I-f

A

inward (funny current–activates with hyperpolarization)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

heart: necessary to initiate electrical activation (functioning pacemaker/autonomic innervation/electrical coupling of myocytes/electromechanical coupling)

A

functioning pacemaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

heart: necessary to ensure propagation of electrical activation (functioning pacemaker/autonomic innervation/electrical coupling of myocytes/electromechanical coupling)

A

excitable myocytes and electrical coupling of myocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

heart: necessary to translate electrical activation into mechanical contraction (functioning pacemaker/autonomic innervation/electrical coupling of myocytes/electromechanical coupling)

A

electromechanical coupling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

heart: (duration of P wave/PR interval/shape of QRS complex/duration of QT interval/degree of QT elevation) reflects rate of atrial activation

A

duration of P wave

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

heart: (duration of P wave/PR interval/shape of QRS complex/duration of QT interval/degree of QT elevation) reflects conduction time from atria to the ventricles

A

PR interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

heart: (duration of P wave/PR interval/shape of QRS complex/duration of QT interval/degree of QT elevation) reflects adaptation of myocardial cells to changing HR

A

duration of QT interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

heart: (duration of P wave/PR interval/shape of QRS complex/duration of QT interval/degree of QT elevation) reflects sequence and rate of activation of the ventricles

A

shape of QRS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

heart: (duration of P wave/PR interval/shape of QRS complex/duration of QT interval/degree of QT elevation) indicative of ischemia

A

degree of QT elevation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

heart: (Na/Ca/K current Kr/transient outward K current/K current Ks) reduces propagation velocity in ventricular myocardium when blocked

A

Na current

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

heart: (Na/Ca/K current Kr/transient outward K current/K current Ks) block of these two currents can shorten the AP without affecting propagation velocity in the ventricular myocardium

A

calcium and Ks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

heart: (Na/Ca/K current Kr/transient outward K current/K current Ks) these two currents are activated during Phase 1 and 2 and do not affect propagation

A

transient outward K current I-to and I-Kr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

heart: phase (0/1/2/3/4) due to activation of fast voltage gated Na channels

A

0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

heart: phase (0/1/2/3/4) due to inactivation of fast sodium channel current and activation of transient outward K current I-to

A

1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

heart: phase (0/1/2/3/4) due to inward calcium channels and outward K channels

A

2 (plateau)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

heart: phase (0/1/2/3/4) due to outward K channels

A

3 (final phase of repolarization)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

heart: phase (0/1/2/3/4) due to inward rectifier K current

A

4 (resting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

heart: conduction of cardiac impulse is (fastest/slowest) in nodal tissues

A

slowest (SA and AV nodes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

heart: conduction of cardiac impulse is (fastest/slowest) in His-Purkinje fibers

A

fastest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

heart: conduction of cardiac impulse in which cells is intermediate velocity

A

atrial and ventricular cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

heart: (increases/decreases) HR: parasympathomimetic agent

A

decreases (hyperpolarize membrane potential)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
heart: (increases/decreases) HR: less negative threshold potential
decreases (will take longer time to reach threshold)
26
heart: (increases/decreases) HR: vagal stimulation
decreases (release of ACh, hyperpolarizes membrane potential)
27
heart: (increases/decreases) HR: increased slope of diastolic depolarization
increases (shorter time to threshold)
28
heart: (increases/decreases) HR: ACh-esterase inhibitors
decreases (prolong affect of ACh, hyperpolarizes membrane potential)
29
heart: (desmosomes/intercalated disks/T tubules/Gap junctions/Bundles of Kent) are low resistance pathways that allow the propagation of the impulse
Gap junctions
30
heart: (desmosomes/intercalated disks/T tubules/Gap junctions/Bundles of Kent) mechanical coupling between cells
desmosomes
31
heart: (desmosomes/intercalated disks/T tubules/Gap junctions/Bundles of Kent) a membrane specialization between cardiac cells
intercalated disk (comprised of desmosomes and gap junctions)
32
heart: (desmosomes/intercalated disks/T tubules/Gap junctions/Bundles of Kent) invaginations of the sarcolemmal membrane into the cell interior
T tubules
33
kidney: (acetazolamide/mannitol/cholothiazide/ tramterene/spironolactone) is a carbonic anhydrase inhibitor which decreases bicarbonate reabsorption in the proximal tubule
acetazolamide
34
kidney: (HCTZ/amiloride/furosemide/isosorbide/indapamide) would benefit a pt taking Lithium having trouble maintaining fluid balance
amiloride (blocks channel mediated lithium uptake by cells in late distal tubule and collecting duct)
35
kidney: (thiazide/amiloride/furosemide/isosorbide/indapamide) may be prescribed to mitigate the effect of lithium induced diuresis, but requires an assessment of blood lithium levels
thiazide--due to the increase in proximal tubule lithium reabsorption when prescribing thiazides in patients taking lithium
36
kidney: (thiazide/amiloride) puts patient at risk for hypokalemia
thiazide
37
kidney: which nephron segment reabsorbs most of the glomerular filtrate
proximal tubule
38
kidney: the increase in urine volume caused by osmotic diuretics is attributed to its effect in the ______ (nephron segment)
proximal tubule
39
kidney: (amiloride/HCTZ/furosemide/acetazolamide/aminophylline): limits ability of kidney to conserve fluid volume and make a hyperosmotic urine
furosemide
40
kidney: (amiloride/HCTZ/furosemide/acetazolamide/aminophylline) decreases solute reabsorption in the medullary thick ascending limb of the LoH, which decreases the counter-current multiplication of solute concentrations
furosemide
41
kidney: what is the free water clearance when the ECF is neither contracted nor expanded, and the edema has been corrected?
0
42
kidney: (toresemide/metolazone/methazolamide/spironolactone/amiloride/isosorbide) inhibits carbonic anhydrase in the proximal tubule
methazolamide
43
kidney: (toresemide/metolazone/methazolamide/spironolactone/amiloride/isosorbide) inhibits Na, K, Cl Cotransport in the thick ascending limb of the loop of Henle.
torsemide
44
kidney: (toresemide/metolazone/methazolamide/spironolactone/amiloride/isosorbide) thiazide like diuretic which inhibits Na, Cl cotransport in the early distal tubule
metolazone
45
kidney: (toresemide/metolazone/methazolamide/spironolactone/amiloride/isosorbide) inhibits Na channels in the late distal tubule and collecting duct
amiloride
46
kidney: (hypoventilation/bicarbonate infusion/ketoacidosis/increasing titratable acid excretion/increasing ECF pCO2) promotes increased renal clearance of salicylate
bicarbonate infusion, raises pH of tubular fluid
47
kidney: intravascular volume = _% of body weight
7%
48
kidney: The Na, Cl cotransporter in the luminal membrane of the early distal tubule is the target of what type of diuretics
thiazide
49
kidney: Thiazide and thiazide-like diuretics block sodium reabsorption at which nephron segment
early distal tubule
50
kidney: what type of diuretic is chlorthalidone
thiazide like
51
kidney: The countercurrent multiplication of the cortical to medullary ion concentration gradient arises from active solute transport in the (thin/thick) ascending limb of the loop of Henle.
thick
52
kidney: renal wasting of K in the urine induced by diuretics results from an increase in (Na secretion/K secretion/Na reabsorption/K reabsorption) in the late distal tubule
Na reabsorption
53
kidney: (lumenal membrane Na/basolateral Na-K-Cl cotransport/basolateral K/basolateral Na-K-ATPase/lumenal membrane K) channels couple increased sodium reabsorption to increased K secretion in the cortical collecting duct
basolateral Na-K-ATPase
54
kidney: thiazide diuretics decrease free water clearance by (a decrease/an increase) in urine osmolarity
an increase
55
kidney: (mannitol/HCTZ/furosemide/spironolactone/bumetanide) corrects hypercalciuria
HCTZ. thiazides induce an increase in Ca reabsorption from the tubular fluid
56
kidney: Most of the sulfonamide diuretics present in the tubular fluid arise from secretion in which part of the nephron
proximal tubule
57
kidney: (amiloride/torsemide/methazolamide/indapamide/dichlorphenamide) most rapidly contracts ECF volume
torsemide (high ceiling loop diuretic which induces the greatest incrase in urine flow rate)
58
kidney: percentage of renal plasma flow normally filtered in the glomerulus is __%
20%
59
kidney: (amiloride/torsemide/methazolamide/indapamide/dichlorphenamide) prevents hypokalemia, is a K sparing diuretic
amiloride
60
kidney: The (ion-ion) cotransporter in the lumenal membrane of the early distal tubule is the target of thiazide diuretics
Na-Cl
61
kidney: (amiloride/torsemide/methazolamide/indapamide/dichlorphenamide) is a high ceiling/loop diuretic
torsemide (inhibits Na, K, 2Cl cotransport in thick ascending limb of LoH)
62
kidney: Amiloride and HCTZ both (decrease/increase) calcium reabsorption in the early and late distal tubule and lower calcium concentration in the urine.
increase (corrects hypercalciuria)
63
kidney: (bumetanide/indapamide/chlorothiazide/triamterene/torsemide) can cause hyperkalemia because it is a K sparing diuretic
triamterene by decreasing K secretion in the late distal tubule
64
kidney: lithium may induce nephrogenic diabetes insipidus by an effect on which segment of the nephron
collecting duct (interferes with ADH to increase water permeability)
65
kidney: (positive/negative) free water clearance is a response to dehydration
negative
66
kidney: acetazolamide increases the concentration of which anion in the tubular fluid
HCO3-
67
kidney: patient with renal dz and decreased GFR has a failure to respond to high ceiling diuretics because of (a decrease/an increase) in plasma organic anions, which prevents tubular secretion of diuretic
an increase
68
kidney: Aldosterone-dependent regulation of Na+ reabsorption occurs in which nephron segment
late distal tubule
69
kidney: (amiloride/torsemide/methazolamide/indapamide/dichlorphenamide) used to prevent stone formation in the kidney
indapamide (thiazide like diuretic)
70
kidney: Diuresis is a symptom of uncontrolled diabetes mellitus. This diuresis results primarily from a decrease in fluid and solute reabsorption in which segment of the nephron?
proximal tubule (due to high glucose levels, the filtered load of glucose exceeds the resorptive capacity of the prox tubule)
71
kidney: High ceiling or loop diurectics induce the largest diuresis by inhibition of solute transport in which nephron segment
the thick ascending loop of Henle
72
kidney: (amiloride/furosemide/indapamide/chlorothiazide/acetazolamide) induces the largest diuresis in the shortest time, reversing a crisis episode of pulmonary edema
furosemide (high ceiling loop diuretic)
73
kidney: the urine osmolarity of someone with nephrogenic diabetes insipidus is (very high/very low)
very low (100mOsm/kg H2O) because the collecting ducts are unresponsive to ADH and therefore impermeable to water)
74
kidney: The kidney functions to maintain ECF osmolality constant while responding to a negative Na+ balance by isosmotically (increasing/decreasing) the ECF volume proportionate to the negative Na+ balance while increasing Na+ reabsorption.
decreasing
75
kidney: Which nephron segment is constitutively “leaky” and unable to maintain an osmotic gradient?
proximal tubule
76
kidney: (chlorothiazide/furosemide/spironolactone/triamterene) compromises the kidney's ability to compensate for dehydration
furosemide--inhibits medullary solute reabsorption in the thick ascending LoH. Over time, this decreases the cortico-medullary solute conc gradient and the magnitude of negative free water clearance.
77
kidney: (mannitol/furosemide/bumetanide/triamterene/HCTZ) compensates for diuretic induced hypokalemia
triamterene, a K sparing diuretic which decreases fractional excretion of K
78
kidney: (amiloride/mannitol/bumetanide/torsemide/chlorothiazide) increases negative free water clearance in patients taking lithium
amiloride (blocks apical membrane channel in late distal tubule and collecting duct which permits access of lithium intracellularly)
79
kidney: thiazide diuretics control polyuria from nephrogenic diabetes insipidus by an indirect effect on (corticomedullary solute gradient/LoH solute transport/glomerular filtration/collecting duct solute transport)
glomerular filtration. thiazide decreases ECF volume which induces a decrease in GFR (decrease GFR leads to decreased urine excretion)
80
kidney: (amiloride/spironolactone/chlorothiazide/acetazolamide/aminophylline) slows the time-dependent renal compensation to ECF volume expansion
chlorothiazide--inhibits solute reabsorption in the diluting segment of the nephron which raises the osmolarity of the tubular fluid and urine, decreasing the positive free water clearance in response to ECF expansion
81
kidney: (amiloride/spironolactone/HCTZ/mannitol/aminophylline) causes hyponatremia in response to excess fluid consumption
HCTZ--inhibits solute reabsorption in the diluting segment of the nephron, raises the osmolarity of tubular fluid and urine, decreases the positive free water clearance in response to ECF volume expansion --> risk for hyponatremia
82
``` kidney: A localized increase in intravascular hydrostatic pressure will drive an ECF fluid shift from the (interstitial/intravascular) to the (interstitial/intravascular) space. ```
from the intravascular to the interstitial
83
kidney: at normal hydrostatic pressure, ECF distribution is __% interstitial and __%intravascular
75% interstitial, 25% intravascular
84
kidney: Which segment of the nephron causes a reduced fractional excretion of Na+ in response to aldosterone?
late distal tubule and collecting duct
85
kidney: an elevated level of ADH would result in a (higher/lower) urine osmolarity
higher urine osmolarity (increases reabsorption of water, negative free water clearance)
86
kidney: (furosemide/chlorothiazide/triamterene/spironolactone/amiloride) is a competitive antagonist of the cytoplasmic aldosterone receptor in the late distal tubule and collecting duct
spironolactone (does not interact with a membrane transport protein)
87
kidney: (amiloride/spironolactone/chlorothiazide/acetazolamide/aminophylline) prevents mountain sickness, controls intraocular fluid pressure, may cause metabolic acidosis
acetazolamide (carbonic anhydrase inhibitor which blocks bicarb transport in proximal tubule)
88
diuretics: (increase/decrease) excretion of sodium
increase, by defn (water follows solute) EXCEPT mannitol
89
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) cause acidosis, increased urinary excretion of HCO3-
carbonic anhydrase inhibitor (acetazolamide)
90
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) cause increased calcium excretion, alkalosis
loop (ethacrynic acid, furosemide, torsemide)
91
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) cause decreased Ca excretion, alkalosis
thiazide (HCTZ, indapamide, metolazone)
92
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) cause acidosis with decreased K excretion
K sparring (amiloride, triamterene, spironolactone, eplerenone)
93
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring): acetazolamide
CA inhib
94
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) ethacrynic acid
loop
95
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) amiloride, triamterene
K sparring
96
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) spironolactone, eplerenone
K sparring
97
diuretics: (carbonic anhydrase inhibitor/loop/thiazide/K sparring) indapamide, metolazone
thiazide
98
antiHTN: if a pt is taking HCTZ already and still has HTN, why is it bad to add furosemide?
best to combine tx from different classes. two diuretics will magnify the side effects of diuretic therapy
99
antiHTN: (beta blockers/loop diuretics/alpha 1 antagonists/thiazide diuretics) have a neutral or beneficial effect on serum lipids
alpha 1 antagonists (the others may raise serum lipids)
100
antiHTN: a cardioselective beta blocker has greater affinity for beta (1/2), and this selectivity is (enhanced/lost) at high concentrations
greater affinity for 1 (1 heart, 2 lungs) but selectivity is lost at high concentrations
101
antiHTN: cardioselective beta blocker WITHOUT intrinsic sympathomimetic activity (metoprolol/acebutolol)
metoprolol. (acebutolol) has intrinsic sympathomimetic activity)
102
antiHTN: pheochromocytoma, oral contraceptives, renal parenchymal dz and renal vascular stenosis can lead to (primary/secondary) HTN
secondary (primary=essential=cause unknown)
103
antiHTN: pts with essential HTN may benefit from (hormone replacement tx/decreased sodium intake)
decreased sodium intake and other lifestyle changes (decrease alcohol, stop using OCPs)
104
antiHTN: ______ is a Zn containing metalloproteinase with two active sites that can break down bradykinin, is found in heart and brain
ACE. most abundant in lung, converts angiotensin I to II
105
antiHTN: recommended to tx HTN in pregnancy (enalapril/losartan/a-methyldopa/captopril/valsartan)
a-methyldopa
106
antiHTN: cardioselective beta blockers decrease (resorption of sodium in nephron/peripheral resistance/cardiac output)
cardiac output
107
antiHTN: (beta 1/beta 2/alpha 1/alpha 2) blocker will reduce vascular resistance by blocking receptors on vascular smooth muscle cells
alpha 1 blocker
108
antiHTN: _____ decreases blood pressure by interfering with the uptake and storage of biogenic amines resulting in depletion or norepinephrine, dopamine, and serotonin in central and peripheral neurons.
Resperpine
109
antiHTN: antihypertensive that may aggravate gout (enalapril/nifedipine/carvedilol/HCTZ/doxasosin)
HCTZ (side effect is increased serum uric acid levels)
110
antiHTN: what does it mean for a beta blocker to have intrinsic sympathomimetic activity (ISA)?
they interact with the beta receptor in a manner that interferes with the actions of endogenous NE but results in stimulation of the adrenergic pathway to varying degrees. Such agents act as competitive inhibitors when endogenous sympathetic activity is high, but act as partial agonist when endogenous sympathetic activity is low.
111
antiHTN: angiotensin receptor blocker (lisinopril/a-methyldopa/losartan/doxasosin)
losartan
112
antiHTN: ACE inhibitor (lisinopril/a-methyldopa/losartan/doxasosin)
lisinopril
113
antiHTN: which TWO drugs are beneficial to pts with diabetes and chronic kidney disease (lisinopril/furosemide/a-methyldopa/losartan/doxasosin)
lisinopril and losartan
114
antiHTN: which drug is associated with cough (lisinopril/a-methyldopa/losartan/doxasosin)
lisinopril ACEi
115
antiHTN: what two classes of drugs should you use when someone with HTN also has diabetes and chronic kidney dz?
ACEi and angiotensin receptor blocker
116
antiHTN: example of an ACEi (propranolol/HCTZ/a-methyldopa/enalapril)
enalapril PRIL (lisinopril)=ACEi
117
antiHTN: what two types of drugs for HTN can cause harm to a developing fetus
ACEi and angiotensin receptor blockers
118
antiHTN: what type of antiHTN is contraindicated in a pt with asthma
beta blocker (beta agonists are used to treat asthma)
119
antiHTN: In patients with bilateral renal artery stenosis, glomerular perfusion pressure is maintained by ____ mediated vasoconstriction of the efferent arterioles.
angiotensin II (therefore, do not give a pt with renal artery stenosis an angiotensin receptor blocker, it could lead to decreased GFR and kidney failure)
120
antiHTN: in a pt at risk of developing osteoporosis, which drug can increase serum Ca levels (enalapril/nifedipine/HCTZ/carvedilol/doxasosin)
HCTZ
121
``` antiHTN: Hydralazine and amlodipine can (decrease/increase) proteinuria in chronic kidney dz ```
increase (bad)
122
antiHTN: beta blockers can (improve/worsen) glycemic control in diabetes mellitus
worsen
123
antiHTN: which antiHTN used in pregnancy can present with a lupus-like syndrome with joint pain and photosensitivity and anemia (amlodipine/losartan/lisinopril/HCTZ/methyldopa)
methyldopa
124
antiHTN: which drug can cause dose-related peripheral edema and reflex tachycardia (amlodipine/losartan/lisinopril/HCTZ/methyldopa)
amlodipine
125
antiHTN: (ACEi's/Ca channel blockers/diuretics/direct vasodilators) have a renoprotective effect due to dilation of the efferent arteriole, thus reducing glomerular hyperfiltration
ACE inhibitors act at the efferent arteriole to decrease vascular resistance (dilate) and therefore, prevent an increase in GFR and hyperfiltration.
126
asthma: (theophylline/cromolyn/betamethasone/prednisone/ipratropium) reverses bronchoconstriction by blocking vagal stimulation
ipratroipium (anticholinergic)
127
asthma: (theophylline/cromolyn/betamethasone/prednisone/ipratropium) anticholinergic
iprotropium
128
asthma: (theophylline/cromolyn/betamethasone/terbutaline/ipratropium) given orally or by IV injection or by suppositories
theophylline (mild to moderate bronchodilator)
129
asthma: (theophylline/cromolyn/salmeterol/albuterol/ipratropium) prevents asthma attacks but does not reverse asthmatic bronchospasm
cromolyn
130
asthma: (theophylline/cromolyn/albuterol/prednisone/zileuton) used to reverse acute onset of asthmatic bronchospasm
albuterol (beta 2 agonist)
131
asthma: albuterol is a beta 2 (antagonist/agonist)
agonist
132
asthma: (theophylline/cromolyn/albuterol/prednisone/ipratropium) decreases reflex bronchoconstriction caused by inhaled irritants
ipratropium (blocks vagal pathway, mediating reflex bronchoconstriction)
133
asthma: oral (beta 2 agonist/corticosteroid) has greatest side effects
oral corticosteroid
134
asthma: (oral/inhaled) corticosteroid has greatest side effects
oral
135
asthma: albuterol decreases bronchoconstriction by acting on (mast cells/basophils.smooth muscle/microvascular endothelium)
smooth muscle
136
``` angina: ____ (drug class) increase myocardial O2 consumption (reflex increased in heart rate and contractility), while others tend to decrease myocardial oxygen consumption (decreased preload with consequent decrease in end -diastolic pressure, decreased systolic blood pressure and decreased ventricular volume). ```
nitrates
137
cardiac: (digoxin/dobutamine/inamrione/dopamine/isoproterenol) inhibits troponin I
digoxin
138
cardiac: (digoxin/dobutamine/inamrione/dopamine/isoproterenol) blocks alpha 2 receptors
isoproterenol
139
cardiac: (digoxin/dobutamine/inamrione/dopamine/isoproterenol) inhibits Na-K ATPase
inamrione
140
cardiac: (digoxin/dobutamine/inamrione/dopamine/isoproterenol) beta 1 receptor agonist, positive inotrope and chronotrope
dobutamine
141
cardiac: (enalapril/propranolol/isosorbide dinitrate/NE/digoxin) for CHF, reduces dyspnea, pulm edema, and systolic dysfunction by decreasing left ventricular afterload
enalapril (ACEi that selective vasodilates arteries)
142
cardiac: (enalapril/propranolol/isosorbide dinitrate/NE/digoxin) reduces cardiac output, do not use for CHF
propranolol
143
cardiac: (enalapril/propranolol/isosorbide dinitrate/NE/digoxin) selective venodilator
isosorbide dinitrate
144
cardiac: treat diastolic heart failure with (dobutamine/verapamil/digoxin/hydralazine/isosorbide dinitrate)
isosorbide dinitrate--reduces filling pressure without reducing cardiac output
145
cardiac: (diastolic/systolic) heart failure: dyspnea, near normal ejection fraction
diastolic
146
cardiac: (diastolic/systolic) heart failure: decreased ejection fraction
systolic
147
cardiac: (dobutamine/verapamil/digoxin/hydralazine/isosorbide dinitrate) is a calcium channel blocker
verapamil
148
cardiac: agents with positive inotropic actions (are/are not) indicated if systolic function is normal
are not
149
cardiac: (dobutamine/verapamil/digoxin/hydralazine/isosorbide dinitrate) is a vasodilator whose major effects occur in the arterial circulation
hydralazine
150
cardiac: (propranolol/dobutamine/carvedilol/bucindolol/inamrione) (2) third-generation beta blockers
carvedilol and bucindolol
151
cardiac: (propranolol/dobutamine/carvedilol/aspirin/inamrione) reduces afterload to counteract the negative inotropic properties of adrenergic withdrawal, may even increase cardiac output
carvedilol (third gen beta blocker)
152
cardiac: (propranolol/dobutamine/carvedilol/aspirin/inamrione) contraindicated in heart failure
propranolol
153
cardiac: (propranolol/dobutamine/carvedilol/aspirin/inamrione) (2) can only be used for in-hospital treatment of heart failure that is refractory to conventional medication
dobutamine and inamrione
154
cardiac: ST elevation in normal complexes suggest what?
myocardial ischemia
155
cardiac: ____ rhythm: a P wave precedes each normal beat
sinus
156
angina: nitroglycerin action (coronary vasodilation/reduced preload/reduced afterload/coronary vasoconstriction/increased ejection time)
reduced preload (relaxation of smooth muscle, especially in venous circulation)
157
cardiac: (phenylephrine/clopidogrel/nitroglycerin/metaraminol/isoproteronol) side effect: orthostatic hypotension
nitroglycerin (weakness, syncope, dizziness)
158
why would you see rapid HR after administration of nitroglycerin?
reflex sympathetic discharge due to a fall in systemic blood pressure
159
atrial flutter: use digitalis to (slow rate of firing at SA node/slow conduction through AV node/decrease refractory period through AV node/decrease rate of conduction through atrial muscle)
slow conduction through AV node by enhancing its vagal tone and diminishing sympathetic activity, direct inhibitory effect on AV propagation
160
nitrates in angina pectoris: (increase preload/decrease systolic BP)
decrease systolic BP. may cause reflex increase in HR, ventricular size decrease, peripheral venous pooling
161
(decreased peripheral resistance/metabolic vasodilation/alpha adrenergic stimulation/release of ACh) causes increase in coronary blood flow during exercise
metab vasodilation
162
nitroglycerin reduces myocardial oxygen needs by reducing (CO/HR/coronary flow/intramyocardial tension)
intramyocardial tension
163
three major determinants of myocardial oxygen consumption: systolic wall tension, contractility, and ___
HR
164
what causes lethargy and weakness in a patient taking furosemide for CHF?
hypokalemia
165
a patient with CHF being treated with furosemide who has developed hypokalemia should receive which type of diuretic in addition?
K sparring, like triamterene
166
when digitalis therapy is initiated, serious cardiac arrhythmias may be caused by what element deficiency? (Na/K/Cl/Ca/Zn)
potassium (take care when using diuretics in conjunction with digitalis)
167
initial treatment of mild CHF (diuretic/Ca channel blocker/phosphodiesterase inhibitor/first gen beta blocker/catecholamine)
diuretic
168
whenever there is an increase in oxygen demand, the coronary vascular resistance (increases/decreases)
decreases, with a consequent increase in coronary blood flow
169
angina pectoris: immediate relief (esmolol/nifedipine/propranolol/nitroglycerin/isosorbide dinitrate)
sublingual nitroglycerin
170
prevents tachycardia induced by a bolus IV injection of nitroglycerin: (propranolol/isoproterenol/phenoxybenzamine/phentolamine/dobutamine)
propranolol--blocks beta receptors in the heart
171
lipids: what type of drug is colestipol
bile acid sequestrant
172
lipids: what type of drug is prescribed for children
bile acid sequestrant (safe)
173
lipids: what type of drug lowers serum cholesterol by inhibiting a sterol transporter in the endothelial cells of the small intestine (PSCSK9 inhib/ezetimibe/HMG CoA Reductase Inhib-statins/bile acid sequestrant/fibrates/niacin)
ezetimibe
174
lipids: what type of drug is colesevelam (PSCSK9 inhib/ezetimibe/HMG CoA Reductase Inhib-statins/bile acid sequestrant/fibrates/niacin)
bile acid sequestrant
175
lipids: what type of drug binds to cholesterol and causes its fecal excretion (PSCSK9 inhib/ezetimibe/HMG CoA Reductase Inhib-statins/bile acid sequestrant/fibrates/niacin)
bile acid sequestrant
176
lipids: what type of drug is bezafibrate
fibrate
177
lipids: what type of drug stimulates fatty acid oxidation and LPL synthesis
fibrate
178
lipids: statins (PSCSK9 inhib/ezetimibe/HMG CoA Reductase Inhib/bile acid sequestrant/fibrates/niacin)
HMG CoA Reductase Inhibitor
179
lipids: ___ inhibits LDL oxidation in arteries, absorbs cholesterol from cell membrane turnover, delivers cholesterol from peripheral tissues to liver
HDL--increased levels decrease risk of CAD
180
lipids: cholesterol (increases/decreases) activity of HMG CoA reductase
decreases
181
lipids: cholesterol (inactivates/activates) ACAT - acetyl coA: cholesterol acetyltransferase
activates
182
lipids: cholesterol (increases/decreases) txn of the LDL receptor gene
decreases
183
lipids: what type of drug produces its effect by binding to and activating the peroxisome proliferator-activated receptor α (PPARα)? (niacin/fibrate/bile acid sequestrant/statin/ezetimibe)
fibrate (ex. fenofibrate)
184
lipids: _____ is a nuclear receptor expressed in skeletal muscle, cardiac muscle, hepatocytes, and macrophages, and fibrates work on this receptor
PPAR alpha
185
lipids: resins have (many/few) side effects and are (rarely/safely) prescribed in combo with statins or ezetimibe
few side effects, safely combined
186
lipids: a combination of fibrate with a ___ (drug type) is inadvisable due to increased risk of myositis
statin
187
lipids: 2 resins (nicotinic acid/bezafibrate/cholestyramine/ezetimibe/colesevelam)
cholestyramine and colesevelam
188
lipids: (nicotinic acid/bezafibrate/cholestyramine/ezetimibe/colesevelam) best agent for increasing HDL-C, lowers triglycerides, and lowers LDL-C by 25%
nicotinic acid
189
lipids: (nicotinic acid/fibrates/ezetimibe/resins) have no effect on HDL-C levels and can actually increase serum TG's (triglycerides)
resins
190
lipids: (nicotinic acid/fibrates/ezetimibe/resins) insignificant effects on TGs and HDL-C levels
ezetimibe
191
lipids: (nicotinic acid/fibrates/ezetimibe/resins) variable effects on LDL-C and modest increases in HDL-C
fibrates
192
lipids: combination tablet of ezetimibe and ____ is marked because of their complementary mechanistic effects on lowering LDL-C levels
simvastatin (Vytorin)
193
lipids: first statin studied in humans, but not marketed as a drug (mevastatin/simvastatin)
mevatatin
194
lipids: how do statins work to lower serum cholesterol levels
increased LDL-receptor gene txn
195
lipids: statins: (increased/decreased) intracellular cholesterol activates an hepatic protease, which activates a sterol regulatory element binding protein (SREBP), which increases transcription of the LDL-R gene. Increased expression of LDL-R increases hepatocyte absorption of LDL-C, thus producing a fall in serum cholesterol levels.
decreased
196
antiarrhythmics: cardiac glycoside toxicity induced v tach is likely caused by (increased pacemaker activity/AV node reentry/early after depolarizations/delayed after depolarizations/atrial ectopic focus)
DADs
197
antiarrhythmics: Increases in diastolic [__ (ion)]i activate a transient inward cation current the produces DADs.
Ca2+
198
antiarrhythmics: cardiac glycosides (do not affect/affect) normal automatic mechanisms
do not affect, and therefore will not increase pacemaker automaticity or an atrial ectopic focus
199
antiarrhythmics: early after depolarizations are enhanced by (increased/decreased) QT interval duration
increased
200
antiarrhythmics: Increasing ___ (ion) currents will suppress EAD formation.
K+
201
antiarrhythmics: ______ are the primary mechanism for prolonged QT interval arrhythmias and are enhanced by increases in INa or ICa,L and slow heart rates.
early after depolarizations
202
antiarrhythmics: Mobitz Type (1/2) 2nd degree AV block, or Wenckebach phenomenon, is characterized by a gradually increasing PR interval until a ventricular beat is dropped.
type 1
203
antiarrhythmics: Which type of cardiac arrhythmia is least likely to require an artificial pacemaker? (sick sinus syndrome/mobitz type II 2nd degree AV block/trifascicular block/3rd degree AV block/Mobitz type I 2nd degree AV block)
mobitz type 1
204
antiarrhythmics: Mobitz Type I 2nd degree AV block is typically caused by excessive vagal tone and usually responds to _____ (M2 receptor blockade).
atropine
205
antiarrhythmics: Wolff Parkinson White syndrome (will/will not) be terminated by vagal stimulation
will not--may become worse
206
antiarrhythmics: v tach (will/will not) be terminated by vagal stimulation
will not
207
antiarrhythmics: Automatic AV junctional tachycardia may be slowed, but not terminated, by vagal stimulation or ______.
adenosine
208
antiarrhythmics: which tachycardia is most likely to be terminated by vagal stimulation? (paroxysmal SVT/atrial tach/automatic AV junctional tach/v tach/WPW syndrome tach)
paroxysmal SVT
209
antiarrhythmics: Atrial tachycardia is usually caused by an | automatic ____ activity and will not be terminated by increased vagal tone.
ectopic
210
antiarrhythmics: drug of choice for Mobitz type I 2nd degree AV block (quinidine/procainamide/propranolol/verapamil/atropine)
atropine--because Mobitz Type I is caused by excessive vagal tone, so it can be reversed by atropine
211
antiarrhythmics: 2 drugs that may worsen heart block (quinidine/procainamide/propranolol/verapamil/atropine)
quinidine and procainamide
212
antiarrhythmics: 2 drugs that further slows AVN conduction in AVN heart block (quinidine/procainamide/propranolol/verapamil/atropine)
propranolol and verapamil
213
antiarrhythmics: Class (Ia/Ib/Ic/II/III/IV) Na channel blockers
Class I
214
antiarrhythmics: Class (Ia/Ib/Ic/II/III/IV) quinidine, procainamide, disopyramide
Ia
215
antiarrhythmics: Class (Ia/Ib/Ic/II/III/IV) lidocaine, mexiletine (oral)
Ib
216
antiarrhythmics: Class (Ia/Ib/Ic/II/III/IV) flecainide, propafenone, moricizine
Ic
217
antiarrhythmics: Class (Ia/Ib/Ic/II/III/IV) beta blockers
II
218
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) propranolol, carvedilol
non selective II
219
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) metoprolol, acebutolol
II beta i selective
220
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) esmolol
fast acting
221
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) prolong phase 3
III
222
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) K channel blockers, sotalol
III
223
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) ibutilide, dofetilide
III
224
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) amiodarone, dronedarone
III mixed
225
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) Ca channel blockers
IV
226
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) phenylalkamines
IV
227
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) verapamil
IV example of phenylalkamine
228
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) benzothiazepines
IV
229
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) diltiazam
IV example of benzothiazepines
230
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) dihydropyridines
IV
231
antiarrhythmics: Class (Ia/Ib/Ic/II non selective/II beta i selective/II fast acting/III/IV) nifeidipine, amlodipine, felodipine, isradipine
IV example of dihydropyridines
232
carhart: contraindicated in seasonal wheezing (atorvastatin/clopidogrel/enalapril/propranolol/valsartan)
propranolol beta blocker contraindicated in asthma
233
carhart: most important ion in determining the electrophysio changes of myocardial ischmia
extracellular K: greatest impact on the AP
234
carhart: dipyridamole increases intracellular cAMP and inhibits the uptake/degradation of (NE/renin/AT I/5-HT/adenosine)
adenosine
235
carhart: dipyridamole inhibits the breakdown of adenosine, which leads to (vasodilation/anti-platelet action)
vasodilation
236
carhart: dipyridamole increases cAMP, which leads to (vasodilation/anti-platelet action)
anti platelet
237
carhart: (oxygen therapy/beta blocker) have a positive impact on mortality in acute ST elevation MI
beta blocker. Oxygen has not demonstrated mortality benefits.
238
carhart: thrombolytic therapy in acute MI with ST elevation (reduces mortality/has no impact on mortality)
reduces mortality. as does aspirin
239
carhart: BNP levels are measured to assess _____ status
volume
240
carhart: lactate levels rise with poor _____
perfusion
241
carhart: __ (ion) levels increase with the use of spironolactone and need to be monitored frequently
K+
242
carhart: what is the effect of spironolactone used in heart failure on Na and creatinine levels?
the dose used in heart failure therapy does not cause significant diuresis
243
carhart: (adenosine/endothelin) causes coronary artery dilation
adenosine
244
carhart: (beta 2 agonists/endothelin) causes smooth muscle contraction and vasoconstriction of coronary arteries
endothelin
245
carhart: peripheral edema side effect (amlodipine/furosemide/isosorbide mononitrate/metolazone/metoprolol)
amolodipine (15% incidence of this effect)
246
carhart: dihydropyridine Ca channel blocker (amlodipine/furosemide/isosorbide mononitrate/metolazone/metoprolol)
amlodipine
247
carhart: (dipyridamole/heparin/clopidogrel/nitroglycerin) has clear anti platelet effects
clopidogrel--thienopyridine derivative
248
carhart: (dipyridamole/heparin/clopidogrel/nitroglycerin) anticoagulant, works on thrombin (not platelets)
heparin
249
carhart: (dipyridamole/heparin/clopidogrel/nitroglycerin) secondary anti platelet effects, but is not considered an aspirin alternative
nitroglycerin
250
carhart: (dipyridamole/heparin/clopidogrel/nitroglycerin) may worsen ischemia
dipyridamole
251
carhart: four drug classes that have a mortality benefit in pt with stable angina
beta blockers, aspirin, ACEi's, statins
252
carhart: (sildenafil/quinidine) quality of life drug in pt with stable angina
sildenafil (viagra)
253
carhart: (sildenafil/quinidine) anti arrhythmic which actually increases risk of death in pt with stable angina
quinidine
254
carhart: nitrates, Ca channel blockers, ticlopidine improve symptoms in pt with stable angina. what is their effect on mortality?
do not demonstrate a survival benefit
255
carhart: ACEi's (increase glomerular filtration pressure/block the release of vasopressin)
block the release of vasopressin. (GFR decreases)
256
``` carhart: thrombolytic contraindications (4) A. Adenocarcinoma of the colon B. Aortic dissection C. Intracranial hemorrhage D. Pregnancy E. Recent facial trauma ```
B. Aortic dissection C. Intracranial hemorrhage D. Pregnancy E. Recent facial trauma
257
``` carhart: absolute contraindications of thrombolytics (3) B. Aortic dissection C. Intracranial hemorrhage D. Pregnancy E. Recent facial trauma ```
B. Aortic dissection C. Intracranial hemorrhage E. Recent facial trauma
258
``` carhart: relative contraindication of thrombolytics (1) B. Aortic dissection C. Intracranial hemorrhage D. Pregnancy E. Recent facial trauma ```
pregnancy
259
carhart: reduced in the setting of heart failure (aldosterone/melatonin/endothelin)
melatonin
260
carhart: elevated in the setting of heart failure (tumor necrosis factor/melatonin)
TNF
261
carhart: what should you give instead if captopril is giving a dry cough
ARB (sartan)
262
carhart: what do statins increase that cause dry cough
bradykinin
263
carhart: treats CAD by relaxing vascular smooth muscle by increasing intracellular cGMP (isosorbide dinitrate/bisoprolol/enalapril)
isosorbide dinitrate
264
carhart: isosorbide dinitrate increases intracellular (cAMP/cGMP)
cGMP
265
carhart: treats CAD by acting on the myocardium (isosorbide dinitrate/bisoprolol/enalapril)
bisoprolol (beta 1 selective)
266
carhart: verapamil and diltiazem are in what drug class
non dihydropyridine Ca channel blockers
267
carhart: nondihydropyridine Ca channel blocker (enalapril/bisoprolol/verapamil)
verapamil
268
carhart: nondihydropyridine Ca channel blocker (isosorbide dinitrate/diltiazem)
diltiazem
269
carhart: used to treat fluid retention in chronic heart failure (diltiazem/aldactone/nifedipine/furosemide)
furosemide
270
carhart: 2 vasodilator drugs (diltiazem/aldactone/nifedipine/furosemide)
diltiazem and nifedipine